Since 1893, activation of the serum proteolytic enzymes has been accomplished by a variety of methods and agents. Activation of the serum proteolytic enzyme by means of streptokinase, the beta hemolytic streptococcal kinase, has been recently demonstrated. The significant plasma and tissue hexosamine changes, as well as the subcutaneous "nodules" which developed at the injection sites, resemble those observed in the trypsin treated group. Although trypsin and the serum proteolytic enzyme are not identical, they have many characteristics in common.
T HE PRESENCE of proteolytic activity of serum was first noted by Dastre' in 1893. Delezene and Pozerski2 in 1903 reported that sera treated with chloroform exhibited proteolytic activity. This observation has been confirmed by subsequent investigators.'-6 Activation of serum protease has been accomplished by a variety of agents and methods.710 Christensenll and Christensen and MacLeod5 have recently demonstrated that serum protease is normally present as a zymogen, plasminogen,5 and is catalytically transformed to an active enzyme, plasmin, by streptokinase, a bacterial kinase. Despite the fact that plasmin and trypsin have many characteristics in common and are considered to be identical by some investigators,"-6 Christensen5' 11 and Kaplan'2 have demonstrated that they are not identical.
This study was prompted by the following considerations: (1) the development of subcutaneous "nodules" in rabbits appeared to be specifically related to the administration of trypsin;17 (2) the fact that plasmin and trypsin From the Department of Therapeutics, New York University College of Medicine, New York, N. Y. This Study was aided by grants from the American Legion and Helen Hay Whitney Foundation. have many characteristics in common ;12 and (3) the fact that plasminogen is converted to plasmin by streptokinase."1 It was decided to ascertain whether a single subcutaneous injection of streptokinase would induce (a) "nodule" formation at the injection site, other local lesions, and/or visceral lesions; (b) any significant changes in tissue and/or plasma hexosamine.'8 MATERIALS AND METHODS Seven young male albino rabbits* were used in this study. These animals ranged in weight from 1.60 to 1.92 kilograms. They were obtained from the same source and fulfilled the same criteria regarding their clinical state as those employed in the previous studies.'" 18 Except for the inoculant, these rabbits were subjected to the same procedures employed in the previous investigation.' 7 18 The control animals employed for this study are the same as those used in the previous studies. '7, 18 Streptokinase.t Partially purified streptokinase made up in a borate buffered solution (pH 7.4) was prepared so that 1.0 ml. of the solution contained 10,000 units. 
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The methods for the measurement of the "nodules," the determination of the hexosamine content of the plasma and tissues, and the statistical treatment of the results which were employed in this study have been described in detail in the previotus reports.", 17 PROCEDURE AND RESULTS In each of a series of 7 rabbits, a single injection of 1.0 ml. of streptokinase solution containing 10,000 units was introduced subcutaneously into the shaved area of the plantar surface of each of the hind legs, which is analogous to the human heel region. A distinct, firm, nontender, elevated mass appeared at the injection site two to four days after the injection. The subcutaneous "nodule" progressively increased in size to reach its maximum in nine to sixteen days, and then slowly regressed (table 1, fig. 1 ). At the end of the experimental period of twenty-one days, the "nodule" although smaller in size, was still present. No erythema, tenderness, fluctuation, eschar, necrosis, slough, breakdown, or fixation to the underlying tissue was associated with the developmental course of the subcutaneous mass.
Twenty-four hours after the single subcutaneous injection of 10,000 units (1.0 ml.) of streptokinase, a significant elevation of the tissue hexosamine content occurred at the injection sites. Thereafter the level of the hexosaamine of the injection sites and "nodules" remained significantly elevated throughout the experimental period of twenty-one days ( fig. 1,  table 2 ).
The hexosamine content of such tissues as the tendons of Achilles, and the skin covering the quadriceps femoralis (a site distant from the injection area), did not exhibit any significant variation from the normal (table 3) . A significant elevation of the plasma hexosamine occurred twenty-four hours after the single subcutaneous injection of streptokinase and persisted throughout the entire twenty-oneday study period ( fig. 2, table 4 ). The developmental course of these "nodules" seemed to be accelerated when compared with that which occurred in the animals inoculated with trypsin. This is demonstrated by the fact that in the streptokinase-treated series, "nodules" appeared in two to four days after injection and reached their maximum size within twelve to sixteen days. In the trypsin-treated series, the "nodules" appeared within four to eight days, and reached their maximum in fourteen to eighteen days.17
The significant elevation of the tissue (injection sites and "nodules") and plasma hexosamine content which occurred soon after the introduction of streptokinase and persisted throughout the period of observation resembled the hexosamine changes observed in the trypsin-treated rabbits.'8 Another feature common to both the streptokinase-inoculated rabbits and trypsin-injected animals is the secondary rise in the hexosamine content of the "nodules" twelve to eighteen days after inoculation ( fig. 1 ) which corresponds to the period when the 'nodules" reached their maximum size.
The inoculating dose of streptokinase was assumed to produce sufficient plasmin not only to neutralize the high antiprotease titer which is present in the rabbit,6 19 but also to insure an excess of the plasmin. The hypothesis that the "nodule" formation and hexosamine changes observed following the injection of streptokinase were due to the plasmin resulting from the activation of the plasminogen by the strep-tokinase5 11 can hardly be made at present. The possible role of desoxyribosenuclease which has been demonstrated to be present in the partially purified streptokinase preparations20 must first be investigated. SUMMARY 1. Two to four days following a single subcutaneous injection of 10,000 units of partially purified streptokinase into the plantar aspect of the hind legs of rabbits, there occurred at the injection site a distinct, firm, nontender, elevated mass. There never was any erythema, tenderness, eschar, necrosis, slough, breakdown, fluctuation, or fixation to the underlying tissues associated with the development of the "nodules." 2. The ' nodules" progressively increased in size to reach their maximum in twelve to sixteen days postinoculation, and then slowly regressed.
3. The injection sites and the "nodules" which subsequently developed exhibited a significant increase in the hexosamifle content, which persisted throughout the twenty-one davs of observation. 4 . A significant increase in the plasma hexosamine content occurred twenty-four hours after the inoculation, and persisted throughout the entire study period.
